
医学资讯ESCCPD-L1阻断
解码细胞互作,提升食管鳞状细胞癌新辅助PD-L1阻断疗效
By MedXY|2026年9月23日
本研究揭示了ESCC对新辅助PD-L1阻断治疗的应答与耐药背后的协同细胞程序,并强调了可用于个体化治疗策略的潜在联合免疫治疗靶点。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.